Sana Biotechnology Stock Target Price and Analyst Consensus
| SANA Stock | USD 2.68 0.09 3.47% |
The current analyst and expert consensus on Sana Biotechnology is Strong Buy, with 3 strong buy opinions. The current projected Sana Biotechnology target price consensus is 9.80 with 7 analyst opinions. Check out Macroaxis Advice on Sana Biotechnology to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Sana Stock refer to our How to Trade Sana Stock guide.The most common way Sana Biotechnology analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Sana Biotechnology executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Sana Biotechnology. We strongly encourage you to use your own analysis of Sana Biotechnology to validate this buy or sell advice. Sana Biotechnology buy-or-sell recommendation module provides average expert sentiment on the projected Sana Biotechnology target price to derive its highest and lowest estimates based on projected price volatility of 22.3609.
Lowest Forecast 8.92 | Highest Forecast 10.88 | Target Price 9.8 |
Sana |
It's important to approach Sana Biotechnology's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Sana Biotechnology Target Price Consensus
Sana target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Sana Biotechnology's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 7 | Strong Buy |
Most Sana analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Sana stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Sana Biotechnology, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationSana Biotechnology Target Price Projection
Sana Biotechnology's current and average target prices are 2.68 and 9.80, respectively. The current price of Sana Biotechnology is the price at which Sana Biotechnology is currently trading. On the other hand, Sana Biotechnology's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Sana Biotechnology Market Quote on 26th of February 2025
Target Price
Analyst Consensus On Sana Biotechnology Target Price
Sana Biotechnology Analyst Ratings
Sana Biotechnology's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Sana Biotechnology stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Sana Biotechnology's financials, market performance, and future outlook by experienced professionals. Sana Biotechnology's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Sana Biotechnology price targets
Sana Biotechnology's stock target price is an estimate of its future price, usually made by analysts. Using Sana Biotechnology's target price to determine if it is a suitable investment can be done through the following steps:- Look at Sana Biotechnology's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Sana Biotechnology's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Sana Biotechnology Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Sana Biotechnology is a key component of Sana Biotechnology valuation and have some predictive power on the future returns of a Sana Biotechnology.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Momentum Invested few shares | |
 | Warren Buffett Holdings Invested over 30 shares | |
 | Hedge Favorites Invested over 60 shares | |
 | Banking Invested over 30 shares | |
 | Adviser Favorites Invested few shares | |
 | Automobiles and Trucks Invested over 60 shares | |
 | Artificial Intelligence Invested few shares | |
 | Chemicals Invested over 30 shares | |
 | Electronic Equipment Invested over 20 shares |
Check out Macroaxis Advice on Sana Biotechnology to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Sana Stock refer to our How to Trade Sana Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Please note, the presentation of Sana Biotechnology's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sana Biotechnology's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sana Biotechnology's management manipulating its earnings.